| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/25/2007 | CN1328381C GnRH-leukotoxin chimeras |
| 07/25/2007 | CN1328319C Synthetic matrix for controlled cell ingrowth and tissue regeneration |
| 07/25/2007 | CN1327898C Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 07/25/2007 | CN1327894C Nucleic acid encoding hyaluronan synthase and method of use |
| 07/25/2007 | CN1327827C Coated granules based on angiotensin-converting enzyme inhibitor |
| 07/25/2007 | CN1327825C Solid oral compositions |
| 07/25/2007 | CN101005857A Polypeptide protracting tags |
| 07/25/2007 | CN101005856A Biomimetic of evodia rutaecarpa fruit extract for amelioration of inflammation |
| 07/25/2007 | CN101005853A Therapeutic composition with a botulinum neurotoxin |
| 07/25/2007 | CN101005846A Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase |
| 07/25/2007 | CN101005834A Eyewash liquid for dry eye therapy |
| 07/25/2007 | CN101005827A Methods and articles for the delivery of therapeutic agents |
| 07/25/2007 | CN101003607A Method for blocking out dendric macromolecule, closed dendric macromolecule and application |
| 07/25/2007 | CN101003387A Method for preparing magnetic Nano composite granules coated by polyelectrolyte of positive ions |
| 07/25/2007 | CN101002947A Target medicine used for treating bacteriosis, and its preparing method |
| 07/25/2007 | CN101002946A Medicine for treating tumor, and its application |
| 07/25/2007 | CN101002945A Novel complexus used for treating tumor |
| 07/25/2007 | CN101002944A Conjugate of branched chair polymacrogol-interferon, and its preparing method |
| 07/25/2007 | CN101002943A Conjugate of branched chain PEG-GCSF and PEG-GMCSF, and its preparing method |
| 07/25/2007 | CN101002942A PEG type elaioplast nanometer particle medicine |
| 07/25/2007 | CN101002941A Anticarcinogen composition carried with platinum compound and vasoinhibitor |
| 07/25/2007 | CN101002939A Medicine composition for treating diseases relating to gastric acid |
| 07/25/2007 | CN101002938A Oral formulation containing itraconazole and methods for manufacturing and using the same |
| 07/25/2007 | CN101002905A Medicine for treating infantile anorexia, its preparing method and quality control method |
| 07/25/2007 | CN101002894A Traditional Chinese medicine for treating rheumatosis and rheumatoid disease |
| 07/25/2007 | CN101002869A Compounding preparation for lowering fat and protecting liver, its preparing method and use |
| 07/25/2007 | CN101002844A Instant granulated medicine for sobering use and its preparing method |
| 07/25/2007 | CN101002830A Health-care capsule |
| 07/25/2007 | CN101002827A Micro-emulsion of mint oil with slow-releasing property, and its preparing method |
| 07/25/2007 | CN101002816A Clathrate containing barrenwort total flavone cyclodextrin or cyclodextrin derivative, preparation and preparing method thereof |
| 07/25/2007 | CN101002809A Medicine preparation containing extractive of Zi-Jin-Sha, preparing method and use thereof |
| 07/25/2007 | CN101002799A Ointment for treating serious burns, and its preparing method |
| 07/25/2007 | CN101002794A Super fine particle of amino-polysaccharide as antineoplastic, and its preparing method |
| 07/25/2007 | CN101002784A Slow release micro-pills containing gastrodin, and its preparing method |
| 07/25/2007 | CN101002782A Medicine composition containing ceftin cyclodextrin clathrate, and its preparing method |
| 07/25/2007 | CN101002780A New pharmaceutical compositions containing flibanserin polymorph a |
| 07/25/2007 | CN101002772A Nanometer particle target preparation of hydroxycamptothecine, and its preparing method |
| 07/25/2007 | CN101002771A Self-assembly precursor liposome containing camptothecine medicine, and its preparing method |
| 07/25/2007 | CN101002769A Compound preparation of omeprazol |
| 07/25/2007 | CN101002768A Series preparation of swainsonine, preparing method and use thereof |
| 07/25/2007 | CN101002765A Compressed formed preparation |
| 07/25/2007 | CN101002758A Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 07/25/2007 | CN101002755A Compounding and pulsation-releasing preparation, and its preparing method |
| 07/25/2007 | CN101002754A Slow release preparation of penthrit |
| 07/25/2007 | CN101002753A Slow release preparation of ethoxy flavonoid |
| 07/25/2007 | CN101002752A Slow release preparation of tropyone |
| 07/25/2007 | CN101002751A Slow release preparation of amitriptyline |
| 07/25/2007 | CN101002750A Slow release preparation of pyrithione alcohol |
| 07/25/2007 | CN101002749A Slow release preparation of nitrofurantion |
| 07/25/2007 | CN101002748A Slow release preparation of cephradine |
| 07/25/2007 | CN101002747A Slow release preparation of cefaclor |
| 07/25/2007 | CN101002746A Slow release preparation of cefuroxime axetil |
| 07/25/2007 | CN101002745A Slow release preparation of cefdinir |
| 07/25/2007 | CN101002744A Slow release preparation of cefalexin |
| 07/25/2007 | CN101002743A Slow release preparation of tizanidine |
| 07/25/2007 | CN101002742A Slow release preparation of silymarin |
| 07/25/2007 | CN101002741A Slow release preparation of Sai-Mi-Xi-Bu |
| 07/25/2007 | CN101002740A Slow release preparation of compactin |
| 07/25/2007 | CN101002739A Slow release preparation of ranitidine |
| 07/25/2007 | CN101002738A Slow release preparation containing tolbutamide |
| 07/25/2007 | CN101002737A Slow release preparation of Kui-Liu-Ping |
| 07/25/2007 | CN101002736A Slow-release preparation containing polyheteroside of tripterygium wilfordii |
| 07/25/2007 | CN101002733A Stable elaioplast composition |
| 07/25/2007 | CN101002732A Germ-free medicinal compsns. |
| 07/25/2007 | CN101002730A Compounding anticarcinogen containing neovascular-inhibitor |
| 07/25/2007 | CN101002729A Slow released anticarcinogen containing vasoinhibitor |
| 07/25/2007 | CN101002728A Preparation of paclitaxel, and its preparing method |
| 07/25/2007 | CA2575649A1 Lanthanide rich nanoparticles, and their investigative uses in mri and related technologies |
| 07/24/2007 | US7247707 Albumin-free factor VIII formulations |
| 07/24/2007 | US7247653 Pharmaceutical composition |
| 07/24/2007 | US7247622 Antibiotic; beta-lactamase inhibitor; therapy for infection |
| 07/24/2007 | US7247609 Growth factor modified protein matrices for tissue engineering |
| 07/24/2007 | US7247502 Nicotine hapten that is nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization |
| 07/24/2007 | US7247501 Imaging and targeting tumors using sickle cells |
| 07/24/2007 | US7247491 Method for determining release of a peptide from a sustained release polylactide formulation |
| 07/24/2007 | US7247452 Isolated polynucleotide; increased biological activity, decreased cytotoxicity as compared to a mature, recombinant, full length KGF expressed in an insect cell expression system |
| 07/24/2007 | US7247444 Use of interleukin-19 to treat cervical cancer |
| 07/24/2007 | US7247331 Isolating milk proteins by passing milk or whey over a cation-exchange resin, eluting the fraction retained by an aqueous salted solution and desalting and sterilizing the eluate; pharmaceutical and food compositions |
| 07/24/2007 | US7247319 Conditioning the quantity of microparticles so that a flowability index of the quantity is greater than about 60 |
| 07/24/2007 | US7247315 Compositions and medical device for transdermal delivery of a drug and methods of making and using same |
| 07/24/2007 | US7247314 Biocompatible material composition adaptable to diverse therapeutic indications |
| 07/24/2007 | US7247312 Hydrophobic polymer carrier containing dispersed particles of an active ingredient that is slightly water soluble or insoluble (especially a vaccine), carbonate particles, and particles of a compound that reacts with the carbonate in an aqueous solution to generate CO2, which accelerates release rate |
| 07/24/2007 | US7247301 Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 07/24/2007 | CA2411277C Neurotoxin implant |
| 07/24/2007 | CA2331348C Positron emission tomography using gallium-68 chelates |
| 07/24/2007 | CA2121798C Novel cytokine |
| 07/24/2007 | CA2110491C Gas filled liposomes and their use as ultrasonic contrast agents |
| 07/24/2007 | CA1341536C Transforming growth factor peptides |
| 07/19/2007 | WO2007081404A1 Skin disinfectant composition and methods for using |
| 07/19/2007 | WO2007080902A1 Composition inhibiting the expression of target gene in eyeball and remedy for disease in eyeball |
| 07/19/2007 | WO2007080898A1 Sustained-release hydrogel preparation |
| 07/19/2007 | WO2007080787A1 Coenzyme q10-containing water-soluble compositions |
| 07/19/2007 | WO2007080776A1 Sustained release preparation and method for production thereof |
| 07/19/2007 | WO2007080114A2 Macromolecule conjugate |
| 07/19/2007 | WO2007079915A2 Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect |
| 07/19/2007 | WO2007062462A8 Method for administering a skin necrosis composition to an animal |
| 07/19/2007 | WO2007059931A8 New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions |
| 07/19/2007 | WO2007048219A3 Sustained drug release composition |
| 07/19/2007 | WO2007016377A3 Dialysis solution including water-soluble polyelectrolyte osmotic agent |
| 07/19/2007 | WO2007014673A3 Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation |